# Septal Mapping And Resynchronisation Therapy- (SMART) Study

> **NCT04595305** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 3 (actual)

## Conditions studied

- Cardiac Resynchronization Therapy
- Heart Failure

## Interventions

- **DEVICE:** Cardiac resynchronization therapy by CRT-P or CRT-D implantation

## Key facts

- **NCT ID:** NCT04595305
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-16
- **Primary completion:** 2021-08-05
- **Final completion:** 2022-08-23
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2022-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04595305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04595305, "Septal Mapping And Resynchronisation Therapy- (SMART) Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04595305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*